Inhibition of TNF-α protects against hepatic ischemia-reperfusion injury in rats via NF-κB dependent pathway

Naunyn-Schmiedeberg's Archives of Pharmacology

Volumn 385, Issue 5, 2012, Pages 465-471

  Mahmoud, Mona F ^a   El Shazly, Shimaa M ^a   Barakat, Waleed ^a  

^a Zagazig University   (Egypt)

Author keywords

Infliximab; Ischemia reperfusion injury; Pentoxifylline; TNF

Indexed keywords

IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INFLIXIMAB; PENTOXIFYLLINE; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOWN REGULATION; LIVER INJURY; MALE; NONHUMAN; OXIDATIVE STRESS; RAT;

ALANINE TRANSAMINASE; ANIMALS; ANTIBODIES, MONOCLONAL; ASPARTATE AMINOTRANSFERASES; GENE EXPRESSION; GLUTATHIONE; L-LACTATE DEHYDROGENASE; LIVER; MALE; MALONDIALDEHYDE; NF-KAPPA B; OXIDATIVE STRESS; PENTOXIFYLLINE; RATS; RATS, WISTAR; REPERFUSION INJURY; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84862888275     PISSN: 00281298     EISSN: 14321912     Source Type: Journal    
DOI: 10.1007/s00210-012-0729-z     Document Type: Article

References (42)

1. Adamy C et al (2005) Tumor necrosis factor alpha and glutathione interplay in chronic heart failure. Arch Mal Coeur Vaiss 98:906-912
2. Asakawa H, Jeppsson B, Mack P, Hultberg B, Hägerstrand I, Beng-mark S (1989) Acute ischemic liver failure in the rat: a reproduc-ible model not requiring portal decompression. Eur Surg Res 21 (1):42-8 (Pubitemid 19072819)
3. Atzeni F, Doria A, Carrabba M, Turiel M, Sarzi-Puttini P (2007) Potential target of infliximab in autoimmune and inflammatory diseases. Autoimmun Rev 6:529-536 (Pubitemid 47374618)
4. Ben-Ari Z, Hochhauser E, Burstein I, Papo O, Kaganovsky E, Krasnov T, Vamichkim A, Vidne BA (2002) Role of anti-tumor necrosis factor-alpha in ischemia/reperfusion injury in isolated rat liver in a blood-free environment. Transplantation 73:1875-1880 (Pubitemid 34700992)
5. Beshay E, Croze F, Prud'homme GJ (2001) The phosphodiesterase inhibitors pentoxifylline and rolipram suppress macrophage acti-vation and nitric oxide production in vitro and in vivo. Clin Immunol 98:272-279
6. Beutler E, Duron O, Kelly BM (1963) Improved method for the determination ofblood glutathione. J Lab Clin Med 61:882-888
7. Bielekova B, Lincoln A, McFarland H, Martin R (2000) Therapeutic potential of phosphodiesterase-4 and -3 inhibitors in Th1-mediated autoimmune diseases. J Immunol 164:1117-1124 (Pubitemid 30043742)
8. Chazouilleres O, Ballet F, Chretien Y, Marteau P, Rey C, Maillard D, Poupon R (1989) Protective effect ofvasodilators on liver func-tion after long hypothermic preservation: a study in the isolated perfused rat liver. Hepatology 9:824-829 (Pubitemid 19140086)
9. Colletti LM, Remick DG, Burtch GD, Kunkel SL, Strieter RM, Campbell DA Jr (1990) Role of tumor necrosis factor-alpha in the pathophys-iologic alterations after hepatic ischemia/reperfusion injury in the rat J Clin Invest 85:1936-1943 (Pubitemid 20192970)
10. Colletti LM, Kunkel SL, Walz A, Burdick MD, Kunkel RG, Wilke CA, Strieter RM (1996) The role of cytokine networks in the local liver injury following hepatic ischemia/reperfusion in the rat Hepatology 23:506-514 (Pubitemid 26087164)
11. Edwards MJ, Abney DL, Miller FN (1991) Pentoxifylline inhibits interleukin-2-induced leukocyte-endothelial adherence and reduces systemic toxicity Surgery 110:199-204
12. El-Ghoneimi A, Cursio R, Schmid-Alliana A, Tovey M, Lasfar A, Michiels JF, Rossi B, Gugenheim J (2007) Pentoxifylline inhibits liver expression of tumor necrosis factor alpha mRNA following normothermic ischemia-reperfusion. HPB (Oxford) 9:112-119 (Pubitemid 46672384)
13. Goto M, Takei Y, Kawano S, Tsuji S, Fukui H, Fushimi H, Nishimura Y, Kashiwagi T, Fusamoto H, Kamada T (1992) Tumor necrosis factor and endotoxin in the pathogenesis of liver and pulmonary injuries after orthotopic liver transplantation in the rat. Hepatol-ogy 16:487-493
14. Hasegawa T, Malle E, Farhood A, Jaeschke H (2005) Generation of hypochlorite-modified proteins by neutrophils during ischemia-reperfusion injury in rat liver: attenuation by ischemic precon-ditioning. Am J Physiol Gastrointest Liver Physiol 289:G760-G767 (Pubitemid 41377184)
15. Helewski KJ, Kowalczyk-Ziomek GI, Czecior E, Swietochowska E, Wielkoszynski T, Czuba ZP, Szliszka E, Krol W (2010) Admin-istration of low doses of tumor necrosis factor-alpha protects rat liver from ischaemic damage and reperfusion injury. J Physiol Pharmacol 61:273-278
16. Jaeschke H (2003) Role ofreactive oxygen species in hepatic ischemia-reperfusion injury and preconditioning. J Invest Surg 16:127-140 (Pubitemid 36926517)
17. Jaeschke H (2006) Mechanisms of liver injury. II. Mechanisms of neutrophil-induced liver cell injury during hepatic ischemia-reperfusion and other acute inflammatory conditions. Am J Phys-iol Gastrointest Liver Physiol 290:G1083-G1088 (Pubitemid 43788288)
18. Jaeschke H, Farhood A (1991) Neutrophil and Kupffer cell-induced oxidant stress and ischemia-reperfusion injury in rat liver. Am J Physiol 260:G355-G362
19. Kim YI, Song KE, Ryeon HK, Hwang YJ, Yun YK, Lee JW, Chun BY (2002) Enhanced inflammatory cytokine production at ischemia/ reperfusion in human liver resection. Hepatogastroenterology 49:1077-1082
20. Lentsch AB, Yoshidome H, Kato A, Warner RL, Cheadle WG, Ward PA, Edwards MJ (1999) Requirement for interleukin-12 in the pathogenesis of warm hepatic ischemia/reperfusion injury in mice. Hepatology 30:1448-1453
21. Lin HI, Chu SJ, Wang D, Feng NH (2004) Pharmacological modula-tion of TNF production in macrophages. J Microbiol Immunol Infect 37:8-15 (Pubitemid 38478608)
22. Llacuna L, Barcena C, Bellido-Martin L, Fernandez L, Stefanovic M, Mari M, Garcia-Ruiz C, Fernandez-Checa JC, Garcia de Frutos P, Morales A (2010) Growth arrest-specific protein 6 is hepatopro-tective against murine ischemia/reperfusion injury. Hepatology 52:1371-1379
23. Maini R et al (1999) Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheuma-toid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group. Lancet 354:1932-1939
24. Martins AM, Nobre AC, Almeida AC, Bezerra G, Lima AA, Fonteles MC, Monteiro HS (2004) Thalidomide and pentoxifylline block the renal effects of supernatants of macrophages activated with Crotalus durissus cascavella venom. Braz J Med Biol Res 37:1525-1530 (Pubitemid 39369040)
25. Menger MD, Vollmar B (2007) Pathomechanisms of ischemia-reperfusion injury as the basis for novel preventive strategies: is it time for the introduction ofpleiotropic compounds? Transplant Proc 39:485-488 (Pubitemid 46386243)
26. Niemann JT, Rosborough JP, Youngquist S, Shah AP, Lewis RJ, Phan QT, Filler SG (2009) Cardiac function and the proinflammatory cytokine response after recovery from cardiac arrest in swine. J Interferon Cytokine Res 29:749-758
27. Okaya T, Lentsch AB (2003) Cytokine cascades and the hepatic inflammatory response to ischemia and reperfusion. J Invest Surg 16:141-147 (Pubitemid 36926518)
28. Pech T, Fujishiro J, Finger T, Ohsawa I, Praktiknjo M, von Websky M, Wehner S, Abu-Elmagd K, KalffJC, Schaefer N (2012) Perioper-ative infliximab application has marginal effects on ischemia-reperfusion injury in experimental small bowel transplantation in rats. Langenbecks Arch Surg 397:131-140
29. Pittoni V, Bombardieri M, Spinelli FR, Scrivo R, Alessandri C, Conti F, Spadaro A, Valesini G (2002) Anti-tumour necrosis factor (TNF) alpha treatment of rheumatoid arthritis (infliximab) selec-tively down regulates the production of interleukin (IL) 18 but not ofIL12 and IL13. Ann Rheum Dis 61:723-725 (Pubitemid 34787711)
30. Rieckmann P, Weber F, Gunther A, Martin S, Bitsch A, Broocks A, Kitze B, Weber T, Borner T, Poser S (1996) Pentoxifylline, a phosphodiesterase inhibitor, induces immune deviation in patients with multiple sclerosis. J Neuroimmunol 64:193-200 (Pubitemid 26096431)
31. Satoh K (1978) Serum lipid peroxide in cerebrovascular disorders deter-mined by a new colorimetric method. Clin Chim Acta 90:37-43 (Pubitemid 9055456)
32. Scales WE, Campbell DA Jr, Green ME, Remick DG (1994) Hepatic ischemia/reperfusion injury: importance of oxidant/tumor necro-sis factor interactions. Am J Physiol 267:G1122-G1127
33. Schwabe RF, Brenner DA (2006) Mechanisms of Liver Injury. I. TNF-alpha-induced liver injury: role ofIKK, JNK, and ROS pathways. Am J Physiol Gastrointest Liver Physiol 290:G583-G589
34. Shen SQ, Zhang Y, Xiang JJ, Xiong CL (2007) Protective effect of curcumin against liver warm ischemia/reperfusion injury in rat model is associated with regulation of heat shock protein and antioxidant enzymes. World J Gastroenterol 13:1953-1961 (Pubitemid 46758857)
35. Sliwa K, Woodiwiss A, Kone VN, Candy G, Badenhorst D, Norton G, Zambakides C, Peters F, Essop R (2004) Therapy of ischemic cardiomyopathy with the immunomodulating agent pentoxifyl-line: results ofarandomized study. Circulation 109:750-755 (Pubitemid 38222895)
36. Solerte SB, Fioravanti M, Cerutti N, Severgnini S, Locatelli M, Pezza N, Rondanelli M, Trecate L, Balza G, Ferrari E (1997) Retrospec-tive analysis of long-term hemorheologic effects of pentoxifylline in diabetic patients with angiopathic complications. Acta Diabetol 34:67-74 (Pubitemid 27434403)
37. Takei Y, Marzi I, Gao WS, Gores GJ, Lemasters JJ, Thurman RG (1991) Leukocyte adhesion and cell death following orthotopic liver transplantation in the rat. Transplantation 51:959-965
38. Teoh N, Leclercq I, Pena AD, Farrell G (2003) Low-dose TNF-alpha protects against hepatic ischemia-reperfusion injury in mice: implications forpreconditioning. Hepatology 37:118-128 (Pubitemid 36042152)
39. Tong Z, Chen B, Dai H, Bauer PC, Guzman J, Costabel U (2004) Extrinsic allergic alveolitis: inhibitory effects ofpentoxifylline on cytokine production by alveolar macrophages. Ann Allergy Asth-ma Immunol 92:234-239 (Pubitemid 38233662)
40. Xu J, Yang Z, Zeng J (2003) Role of NF-kappa B in liver ischemia reperfusion injury ofrats. J Huazhong Univ Sci Technolog Med Sci 23:158-160 (Pubitemid 41559745)
41. Yang YL, Li JP, Xu XP, Dou KF, Yue SQ, Li KZ (2004) Protective effects of tumor necrosis factor alpha antibody and ulinastatin on liver ischemic reperfusion in rats. World J Gastroenterol 10:3161-3164
42. Zapolska-Downar D, Naruszewicz M (2009) Propionate reduces the cytokine-induced VCAM-1 and ICAM-1 expression by inhibiting nuclear factor-kappa B (NF-kappaB) activation. J Physiol Phar-macol 60:123-131